The Albert B Sabin Vaccine Institute Inc

Analysis

The Albert B Sabin Vaccine Institute Inc is a registered charity in United States, based in Washington, DC. It received its IRS tax-exemption ruling in October 1994, 32 years ago. Its declared purposes cover unknown, which this site groups under other charitable purposes. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, The Albert B Sabin Vaccine Institute Inc reported income of $40.1m and spending of $42.2m, spending 105% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $9.5m to $40.1m (+320%), an average of +43% a year. The sharpest change came in the year to December 2020, when income rose by 143%. Over the whole period it spent 101% of the income it received.

Among 72,936 United States charities whose main cause is other charitable purposes and that reported income, The Albert B Sabin Vaccine Institute Inc sits at the 99th percentile: it is larger than about 99% of them. Against every charity in United States with reported income it ranks in the 98th percentile, and in the 96th percentile within DC. Charities of a similar size with the same main cause include Capstone Health Services Foundation P C ($40.1m), Family Institute ($40.1m) and The American University of Paris Inc ($40.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 1.7% and program service revenue 98% of the total. Compensation of current officers, directors and key employees was $1.2m (2.8% of expenses). Other salaries and wages came to $7.0m. At year end it held assets of $15.4m against liabilities of $3.1m, net assets of $12.3m. It reported 84 employees.